GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"GenoType® MTBDRsl Assay for Resistance to Second‐line Anti‐tuberculosis Drugs." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/Cilostazol_for_intermittent_claudication:_Cochrane_systematic_review. Accessed 18 April 2024.
GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/Cilostazol_for_intermittent_claudication:_Cochrane_systematic_review. Accessed April 18, 2024.
GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/Cilostazol_for_intermittent_claudication:_Cochrane_systematic_review
GenoType® MTBDRsl Assay for Resistance to Second‐line Anti‐tuberculosis Drugs [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/Cilostazol_for_intermittent_claudication:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
ID - 431351
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431351/all/Cilostazol_for_intermittent_claudication:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -